Tower Research Capital LLC (Trc) Collegium Pharmaceutical, Inc Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 4,711 shares of COLL stock, worth $137,325. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,711
Previous 10,250
54.04%
Holding current value
$137,325
Previous $330,000
44.85%
% of portfolio
0.0%
Previous 0.01%
Shares
27 transactions
Others Institutions Holding COLL
# of Institutions
255Shares Held
36.9MCall Options Held
100KPut Options Held
21.1K-
Black Rock Inc. New York, NY5.79MShares$169 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$76.8 Million1.79% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.59MShares$75.5 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.35MShares$68.4 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.66MShares$48.3 Million0.1% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $995M
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...